XML 55 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
INVESTMENTS IN CONSOLIDATED AND UNCONSOLIDATED ENTITIES - Summarized Statements of Operations of Unconsolidated Entities Accounted by Equity Method (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Schedule of Equity Method Investments [Line Items]        
Costs and expenses $ (1,476,704) $ (1,466,301) $ (4,240,243) $ (4,000,249)
Net income 309,231 172,467 780,846 399,665
Equity Method Investments | Equity Method Investment, Nonconsolidated Investee or Group of Investees        
Schedule of Equity Method Investments [Line Items]        
Revenues 25,495 21,833 150,062 101,458
Costs and expenses (27,310) (16,647) (145,238) (73,705)
Net income (1,815) 5,186 4,824 27,753
TMHC’s share in (loss)/income of unconsolidated entities (1,180) 1,482 (2,986) 9,269
Distributions to TMHC from unconsolidated entities $ 10,006 $ 2,945 $ 100,835 $ 23,287